Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Rio Tinto plc. ( RIO - Analyst Report ) reported weak financial results in half-year 2012. Net earnings attributable to ADR holders of Rio Tinto were $5,885 million during the period, down 22% year over year from $7,587 million reported in half-year 2011, hurt by lower prices.
Earnings per ADR from continuing operations were approximately $3.16 compared with $3.87 in the comparable period last year. Reported earnings also missed the Zacks Consensus Estimate of $3.30.
Consolidated sales in half-year 2012 moved down to $25,336 million from $29,056 million recorded a year ago. The decline in sales resulted from lower demand for metals and minerals from China, Europe as well as the US.
Operating profit in the reported period stood at $6,662 million compared with $11,056 million in the year-ago period. Operating margin dropped to 26.3% from 38.1% in the previous year. Underlying EBITDA plunged 29% to $10,079 million from $14,253 million in the comparable period last year.
The company’s capital expenditure increased to $7,561 million in the reported period from $5,134 million in the same period last year, due to Rio’s investment in property, plant & equipment and intangible assets.
Net cash generated from operating activities was $3,315 million compared with $8,656 million in the year-ago period. Cash and cash equivalents came in at $7,286 million compared with $9,670 million a year ago.
Consistent with its previous guidance, Rio announced a 34% year-over-year hike in its dividend payout to 72.5 cents per share. Rio’s $7 billion share buy-back program was completed at the end of the first operational quarter of 2012.
Headquartered in London, UK, Rio Tinto plc is engaged in exploring, mining, and processing the earth's mineral resources, producing a broad range of metals and minerals. Rio Tinto competes against global mining giants like BHP Billiton Ltd ( BHP - Analyst Report ) and Vale S.A ( VALE - Analyst Report ) .
Rio Tinto has a Zacks #5 Rank, reflecting a short-term (1-3 months) Strong Sell rating.
Read the full Analyst Report on RIO
Read the full Analyst Report on VALE
Read the full Analyst Report on BHP